{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:47:33Z","timestamp":1792072053507,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.japh.2026.103524","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:56:49Z","timestamp":1789721809000},"page":"103524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Performance of large language models on narrow therapeutic index drug monitoring: Implications for clinical pharmacy practice"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2140-2795","authenticated-orcid":false,"given":"Helia","family":"Azmakan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0219-5852","authenticated-orcid":false,"given":"Tahmour","family":"Azmakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2026.103524_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of therapeutic drug monitoring","volume":"24","author":"Kang","year":"2009","journal-title":"Korean J Intern Med"},{"issue":"5","key":"10.1016\/j.japh.2026.103524_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00228-015-1832-0","article-title":"Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide","volume":"71","author":"Tamargo","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.japh.2026.103524_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.22270\/jddt.v13i10.6251","article-title":"Therapeutic drug monitoring: a review","volume":"13","author":"Ranjan","year":"2023","journal-title":"J Drug Deliv Ther"},{"key":"10.1016\/j.japh.2026.103524_bib4","series-title":"Basic Clinical Pharmacokinetics","first-page":"548","author":"Winter","year":"2010"},{"issue":"2","key":"10.1016\/j.japh.2026.103524_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cpt.2008","article-title":"Clinical pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C9 and HLA-B genotypes and phenytoin dosing: 2020 update","volume":"109","author":"Karnes","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.japh.2026.103524_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1179892","article-title":"Review: failure of current digoxin monitoring for toxicity: new monitoring recommendations to maintain therapeutic levels for efficacy","volume":"10","author":"Gona","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.japh.2026.103524_bib7","author":"Iorga"},{"issue":"39","key":"10.1016\/j.japh.2026.103524_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.54905\/disssi.v17i39.e15dd1015","article-title":"Therapeutic drug monitoring: fundamentals and optimization","volume":"17","author":"S Ali","year":"2023","journal-title":"Drug Discov"},{"issue":"5","key":"10.1016\/j.japh.2026.103524_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285717","article-title":"Vancomycin prescribing and therapeutic drug monitoring: challenges of real clinical practice","volume":"18","author":"Abdel Jalil","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.japh.2026.103524_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2026.103019","article-title":"ChatGPT-5 for drug\u2013drug interaction detection in the intensive care unit: a real-world cohort study on large language model advances and implications for clinical pharmacists","volume":"66","author":"Azmakan","year":"2026","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.japh.2026.103524_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ibmed.2026.100417","article-title":"ChatGPT as a digital pharmacist: a systematic review of medication counselling accuracy","volume":"15","author":"Azmakan","year":"2026","journal-title":"Intell Based Med"},{"issue":"8","key":"10.1016\/j.japh.2026.103524_bib12","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41591-023-02448-8","article-title":"Large language models in medicine","volume":"29","author":"Thirunavukarasu","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.japh.2026.103524_bib13","article-title":"Assessing accuracy of ChatGPT in response to questions from day to day pharmaceutical care in hospitals","volume":"15","author":"Van Nuland","year":"2024","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"6","key":"10.1016\/j.japh.2026.103524_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1515\/labmed-2025-0220","article-title":"Using large language models for therapeutic drug monitoring reporting \u2013 a proof-of-concept","volume":"49","author":"Adler","year":"2025","journal-title":"J Lab Med"},{"issue":"2","key":"10.1016\/j.japh.2026.103524_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/scipharm94020034","article-title":"Leveraging ChatGPT for vancomycin therapeutic drug monitoring: simulation using bayesian estimation and hyperparameter optimization","volume":"94","author":"Kageyama","year":"2026","journal-title":"Sci Pharm"},{"issue":"11","key":"10.1016\/j.japh.2026.103524_bib16","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.3390\/jcm15114082","article-title":"Language-specific differences in large language model diagnostic reasoning: a translation-controlled clinical vignette study","volume":"15","author":"Ibrahim-El-Nur","year":"2026","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.japh.2026.103524_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.4003","article-title":"Large language model performance and clinical reasoning tasks","volume":"9","author":"Rao","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.japh.2026.103524_bib18","article-title":"Ataxia and seizures despite phenytoin: a case report highlighting the importance of TDM and genetic influences","volume":"2024","author":"Manoj","year":"2024","journal-title":"Case Rep Neurol Med"},{"issue":"1","key":"10.1016\/j.japh.2026.103524_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/08971900241262379","article-title":"The phenytoin Ataxia Enigma unveiled \u201cA Case Report\u2019\u2019","volume":"38","author":"Khadela","year":"2025","journal-title":"J Pharm Pract"},{"issue":"3","key":"10.1016\/j.japh.2026.103524_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.18203\/2319-2003.ijbcp20261126","article-title":"A rare presentation of phenytoin toxicity triggered by isoniazid in reactivated pulmonary TB","volume":"15","author":"Maryam","year":"2026","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.japh.2026.103524_bib21","first-page":"138","article-title":"[Severe phenytoin intoxication in patients with hypoalbuminaemia]","volume":"151","author":"Kemper","year":"2007","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"1","key":"10.1016\/j.japh.2026.103524_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40780-024-00374-6","article-title":"Patient resuscitated after cardiopulmonary arrest exhibits abnormally increased phenytoin metabolic rate due to unknown factors: a case report","volume":"10","author":"Nagamine","year":"2024","journal-title":"J Pharm Health Care Sci"},{"issue":"1","key":"10.1016\/j.japh.2026.103524_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s13256-023-04033-6","article-title":"Phenytoin-induced dyskinesia: a case report","volume":"17","author":"Shah","year":"2023","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.japh.2026.103524_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008023","article-title":"When less is more: a case of phenytoin toxicity","volume":"2013","author":"Robertson","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.japh.2026.103524_bib25","article-title":"Digoxin toxicity with therapeutic serum digoxin concentrations","volume":"15","author":"Graafsma","year":"2025","journal-title":"Toxicol Rep"},{"issue":"4","key":"10.1016\/j.japh.2026.103524_bib26","doi-asserted-by":"crossref","first-page":"A669","DOI":"10.1016\/j.chest.2024.06.457","article-title":"Digoxin toxicity in a patient with SICK SINUS syndrome: a case complicated by acute kidney injury and concurrent amiodarone use","volume":"166","author":"Nguyen","year":"2024","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.japh.2026.103524_bib27","article-title":"Digoxin toxicity in renal failure: resolution with plasma exchange after Fab therapy failure","volume":"17","author":"Williams","year":"2025","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.japh.2026.103524_bib28","article-title":"A case of digoxin toxicity due to acute renal failure","volume":"13","author":"Digiovanni-Kinsley","year":"2021","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.japh.2026.103524_bib29","article-title":"Digoxin toxicity in a patient with pacemaker: a case report","volume":"11","author":"Bridwell","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.japh.2026.103524_bib30","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.924025","article-title":"Xanthopsia due to digoxin toxicity as a cause of traffic accidents: a case report","volume":"21","author":"Haruna","year":"2020","journal-title":"Am J Case Rep"},{"issue":"2","key":"10.1016\/j.japh.2026.103524_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4212\/cjhp.v75i2.3069","article-title":"Chronic digoxin toxicity leading to institutionalization of an elderly woman","volume":"75","author":"Nix","year":"2022","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.japh.2026.103524_bib32","volume":"495","author":"Baxter","year":"2010"},{"issue":"7","key":"10.1016\/j.japh.2026.103524_bib34","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.japh.2026.103524_bib35","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/epi.16395","article-title":"Executive summary: management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy","volume":"60","author":"Tomson","year":"2019","journal-title":"Epilepsia"},{"issue":"18","key":"10.1016\/j.japh.2026.103524_bib36","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American college of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.japh.2026.103524_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.amjmed.2024.08.018","article-title":"Expert consensus on the diagnosis and management of digoxin toxicity","volume":"138","author":"Hack","year":"2025","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.japh.2026.103524_bib39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.japh.2026.103524_bib40","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.japh.2026.103524_bib41","series-title":"Disposition of Toxic Drugs and Chemicals in Man","first-page":"1250","author":"Broussard","year":"2004"},{"issue":"7","key":"10.1016\/j.japh.2026.103524_bib42","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2014best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE commission on therapeutic strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.japh.2026.103524_bib43","doi-asserted-by":"crossref","DOI":"10.2196\/72153","article-title":"Clinical large language model evaluation by expert review (CLEVER): framework development and validation","volume":"4","author":"Kocaman","year":"2025","journal-title":"Jmir Ai"},{"issue":"10","key":"10.1016\/j.japh.2026.103524_bib44","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1111\/bcp.16212","article-title":"Appropriateness of ChatGPT as a resource for medication-related questions","volume":"90","author":"Grossman","year":"2024","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.japh.2026.103524_bib45","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.japh.2023.11.023","article-title":"Effectiveness of ChatGPT in clinical pharmacy and the role of artificial intelligence in medication therapy management","volume":"64","author":"Roosan","year":"2024","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.japh.2026.103524_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/20420986251339358","article-title":"Can large language models detect drug\u2013drug interactions leading to adverse drug reactions?","volume":"16","author":"Sicard","year":"2025","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"10.1016\/j.japh.2026.103524_bib47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/bcp.15896","article-title":"Evaluating the performance of ChatGPT in clinical pharmacy: a comparative study of ChatGPT and clinical pharmacists","volume":"90","author":"Huang","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.japh.2026.103524_bib48","doi-asserted-by":"crossref","DOI":"10.2196\/48659","article-title":"Assessing the utility of ChatGPT throughout the entire clinical workflow: development and usability study","volume":"25","author":"Rao","year":"2023","journal-title":"J Med Internet Res"},{"issue":"10","key":"10.1016\/j.japh.2026.103524_bib49","doi-asserted-by":"crossref","DOI":"10.1056\/AIdbp2500120","article-title":"Assessment of large language models in clinical reasoning: a novel benchmarking study","volume":"2","author":"McCoy","year":"2025","journal-title":"NEJM AI"},{"key":"10.1016\/j.japh.2026.103524_bib50","doi-asserted-by":"crossref","DOI":"10.2196\/66917","article-title":"Benchmarking the confidence of large language models in answering clinical questions: cross-sectional evaluation study","volume":"13","author":"Omar","year":"2025","journal-title":"JMIR Med Inform"},{"issue":"1","key":"10.1016\/j.japh.2026.103524_bib51","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41467-024-55628-6","article-title":"Large language models lack essential metacognition for reliable medical reasoning","volume":"16","author":"Griot","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.japh.2026.103524_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jamia\/ocae254","article-title":"Large language model uncertainty proxies: discrimination and calibration for medical diagnosis and treatment","volume":"32","author":"Savage","year":"2025","journal-title":"J Am Med Inform Assoc"},{"issue":"10","key":"10.1016\/j.japh.2026.103524_bib53","article-title":"Large language model as clinical decision support system augments medication safety in 16 clinical specialties","volume":"6","author":"Ong","year":"2025","journal-title":"Cell Rep Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126005091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126005091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:08:40Z","timestamp":1792069720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319126005091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S1544319126005091"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2026.103524","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of large language models on narrow therapeutic index drug monitoring: Implications for clinical pharmacy practice","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2026.103524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103524"}}